Abstract
On-line HPLC-NMR chemical profiling of crude extracts derived from the bulbs of the Australian carnivorous plant Drosera erythrohiza subspecies magna was undertaken. A combination of on-flow and stop-flow HPLC-NMR methodologies enabled partial identification of two structurally related naphthoquinones as well as a mixture of their corresponding glycosides. Subsequent semi-preparative HPLC off-line isolation followed by NMR spectroscopic and mass spectrometric analysis of crude extracts of the bulbs of the plant permitted the unequivocal identification of droserone, hydroxydroserone, droserone-5-O-β-glycoside and hydroxydroserone-5-O-β-glycoside. In addition off-line separation methodologies of the aerial parts of the plant led to the identification of the bioactive compound plumbagin. This study represents only the second application of HPLC-NMR to chemically profile crude extracts of an Australian plant.
Keywords: Carnivorous plant, chemical profiling, droseraceae, drosera, glycosides, HPLC-NMR, naphthoquinones, natural products
The Natural Products Journal
Title:HPLC-NMR Chemical Profiling of the Australian Carnivorous Plant, Drosera erythrohiza subspecies magna
Volume: 3 Issue: 1
Author(s): Michael Anthony Timmers, Daniel Anthony Dias and Sylvia Urban
Affiliation:
Keywords: Carnivorous plant, chemical profiling, droseraceae, drosera, glycosides, HPLC-NMR, naphthoquinones, natural products
Abstract: On-line HPLC-NMR chemical profiling of crude extracts derived from the bulbs of the Australian carnivorous plant Drosera erythrohiza subspecies magna was undertaken. A combination of on-flow and stop-flow HPLC-NMR methodologies enabled partial identification of two structurally related naphthoquinones as well as a mixture of their corresponding glycosides. Subsequent semi-preparative HPLC off-line isolation followed by NMR spectroscopic and mass spectrometric analysis of crude extracts of the bulbs of the plant permitted the unequivocal identification of droserone, hydroxydroserone, droserone-5-O-β-glycoside and hydroxydroserone-5-O-β-glycoside. In addition off-line separation methodologies of the aerial parts of the plant led to the identification of the bioactive compound plumbagin. This study represents only the second application of HPLC-NMR to chemically profile crude extracts of an Australian plant.
Export Options
About this article
Cite this article as:
Anthony Timmers Michael, Anthony Dias Daniel and Urban Sylvia, HPLC-NMR Chemical Profiling of the Australian Carnivorous Plant, Drosera erythrohiza subspecies magna, The Natural Products Journal 2013; 3 (1) . https://dx.doi.org/10.2174/2210315511303010008
DOI https://dx.doi.org/10.2174/2210315511303010008 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course
Current Cancer Therapy Reviews Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
Current Genomics Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy The Development of Cytokine Receptor Antagonists as Potential Therapeutic Agents for the Myeloproliferative Disorders
Current Pharmaceutical Design Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Current Genomics Telomere Maintenance Mechanisms in Cancer: Clinical Implications
Current Pharmaceutical Design The Significance of Transferrin Receptors in Oncology: the Development of Functional Nano-based Drug Delivery Systems
Current Drug Delivery Zebrafish as a Model for the Study of the Phase II Cytosolic Sulfotransferases
Current Drug Metabolism Small-Molecule Inhibitors Targeting eIF4A in Leukemia
Current Protein & Peptide Science Medicinal Research Progress of Natural Coumarin and its Derivatives
The Natural Products Journal DNA and RNA Code-reading Molecules as Potential Gene Silencers in Neurobiology- What are They and what are They Good for?
Current Medicinal Chemistry - Central Nervous System Agents Synthesis and Bioactivity of (R)-Ricinoleic Acid Derivatives: A Review
Current Medicinal Chemistry Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?
Current Cancer Drug Targets Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance
Anti-Cancer Agents in Medicinal Chemistry Interferon-α Treatment in Systemic Mastocytosis
Current Drug Targets Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Immune Response Manipulation: Recombinant Immunoreceptors Endow T-Cells with Predefined Specificity
Current Pharmaceutical Design